Dr. Nathan T. Connell, MD, MPH

Dr. Connell practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Connell's NPI, 1245432467, was assigned on June 1, 2007. Dr. Connell graduated from University of Miami, Miller School of Medicine in 2007. Dr. Connell holds Massachusetts license 258434.

Dr. Connell's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Connell's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Connell is also affiliated with Massachusetts General Hospital. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Dr. Connell to 3 more hospitals, 3 medical groups and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Connell practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Connell's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Connell is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Connell's licenses on file in 2 states: Massachusetts and Rhode Island.

Dmand AI lists chronic anemia, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Connell treats.

CMS data shows 1,259 Medicare services from Dr. Connell across 3 procedure codes in 2024, for 264 Medicare patients. Medicare paid $38,172 for them.

CMS counts 264 Medicare patients who saw Dr. Connell in 2024. The largest group is 65 to 74, with 121 patients. 72% of them have high blood pressure, and 70% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Connell's median patient age at 46, with 65% women.

In 2023, Dr. Connell wrote 11 Medicare Part D claims. They cover 1 drug, with $16,489 in total drug cost. In 2022, CMS named 99 claims across 3 drugs.

Dr. Connell accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 62 papers to Dr. Connell, published from 2011 to 2025. 2022 was the busiest year, with 8. The most frequent topics are von Willebrand Diseases, Hemorrhage and Anticoagulants. Dr. Connell has published most often in Blood Adv. Dr. Connell's most frequent co-authors are Jean M. Connors, MD, Veronica H. Flood, MD and Nedaa M. Husainat, MD.

CMS Open Payments shows 92 general payments to Dr. Connell from 7 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 54% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $64,615.

Dmand AI lists 1 award for Dr. Connell, most recently Member in 2014.

Dr. Connell graduated from University of Miami, Miller School of Medicine in 2007. Dr. Connell is a member of ACP, ASH, Hemostasis and Thrombosis Research Society and International Society on Thrombosis and Haemostasis.

Dr. Connell is in network with 16 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Massachusetts. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.